Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

AMPA receptor positive allosteric modulators: a patent review.

Pirotte B, Francotte P, Goffin E, de Tullio P.

Expert Opin Ther Pat. 2013 May;23(5):615-28. doi: 10.1517/13543776.2013.770840. Epub 2013 Feb 13. Review.

PMID:
23405869
2.

Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.

Pirotte B, Francotte P, Goffin E, Fraikin P, Danober L, Lesur B, Botez I, Caignard DH, Lestage P, de Tullio P.

Curr Med Chem. 2010;17(30):3575-82. Review.

PMID:
20738245
3.

In search of novel AMPA potentiators.

Francotte P, de Tullio P, Fraikin P, Counerotte S, Goffin E, Pirotte B.

Recent Pat CNS Drug Discov. 2006 Nov;1(3):239-46. Review.

PMID:
18221205
4.

DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

Bernard K, Danober L, Thomas JY, Lebrun C, Muñoz C, Cordi A, Desos P, Lestage P, Morain P.

CNS Neurosci Ther. 2010 Oct;16(5):e193-212. doi: 10.1111/j.1755-5949.2009.00088.x.

PMID:
21050420
5.

[Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].

Raevskiĭ KS, Eremin KO.

Biomed Khim. 2004;50(6):523-38. Review. Russian.

PMID:
15707268
6.

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.

Yamada KA.

Expert Opin Investig Drugs. 2000 Apr;9(4):765-78. Review.

PMID:
11060708
7.

S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.

Lockhart BP, Rodriguez M, Mourlevat S, Peron P, Catesson S, Villain N, Galizzi JP, Boutin JA, Lestage P.

Eur J Pharmacol. 2007 Apr 30;561(1-3):23-31. Epub 2007 Feb 1.

PMID:
17331496
8.

AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications.

Ward SE, Pennicott LE, Beswick P.

Future Med Chem. 2015;7(4):473-91. doi: 10.4155/fmc.15.4. Review.

PMID:
25875874
9.
10.

AMPA receptor potentiators for the treatment of CNS disorders.

O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. Review.

PMID:
15180479
11.

Recent advances in positive allosteric modulators of the AMPA receptor.

Morrow JA, Maclean JK, Jamieson C.

Curr Opin Drug Discov Devel. 2006 Sep;9(5):571-9. Review.

PMID:
17002217
12.
13.

AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.

Chang PK, Verbich D, McKinney RA.

Eur J Neurosci. 2012 Jun;35(12):1908-16. doi: 10.1111/j.1460-9568.2012.08165.x. Review.

PMID:
22708602
14.

Recent advances in the discovery of selective AMPA receptor positive allosteric modulators.

Ward SE, Harries M.

Curr Med Chem. 2010;17(30):3503-13. Review.

PMID:
20738249
15.

mGluR2 positive allosteric modulators: a patent review (2009 - present).

Trabanco AA, Cid JM.

Expert Opin Ther Pat. 2013 May;23(5):629-47. doi: 10.1517/13543776.2013.777043. Epub 2013 Mar 2. Review.

PMID:
23452205
16.

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature.

Lindsley CW, Hopkins CR.

Expert Opin Ther Pat. 2012 May;22(5):461-81. doi: 10.1517/13543776.2012.679437. Epub 2012 Apr 16. Review.

PMID:
22506633
17.
19.

5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.

Ivachtchenko AV, Ivanenkov YA, Skorenko AV.

Expert Opin Ther Pat. 2012 Oct;22(10):1123-68. Epub 2012 Sep 7. Review.

PMID:
22957857
20.

AMPA Receptors as Therapeutic Targets for Neurological Disorders.

Lee K, Goodman L, Fourie C, Schenk S, Leitch B, Montgomery JM.

Adv Protein Chem Struct Biol. 2016;103:203-61. doi: 10.1016/bs.apcsb.2015.10.004. Epub 2015 Nov 19. Review.

PMID:
26920691

Supplemental Content

Support Center